All Work

Chris Lange

Will CRISPR Stock Double in the Next Year?

One big Wall Street name thinks it has found a big winner in this gene-editing company, and the stock could benefit greatly going forward.

Chris Lange · 4 years ago

The Case for Kraft Heinz and 25% Upside

One big Wall Street name thinks it has found a big winner within the consumer defensive sector, and this stock could benefit greatly going forward.

Chris Lange · 4 years ago